Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository Originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654) Design, Intent, and Availability of Specimens for Validation of Lung Cancer Biomarkers

National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen... EDITORIAL National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository Originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654) Design, Intent, and Availability of Specimens for Validation of Lung Cancer Biomarkers Edward F. Patz, Jr., MD,*† Neil E. Caporaso, PhD,‡ Steven M. Dubinett, MD,§ Pierre P. Massion, MD, Fred R. Hirsch, MD, PhD,¶ John D. Minna, MD,# Constantine Gatsonis, PhD,** Fenghai Duan, PhD,** Amanda Adams, MPH,** Charles Apgar, MBA,†† Rosa M. Medina, BS,†† and Denise R. Aberle, MD‡‡ he National Lung Cancer Screening Trial (NLST) is a cooperative, National Cancer TInstitute (NCI)-sponsored randomized trial that was initiated in 2002 with the primary goal to determine whether screening for lung cancer with computed tomography (CT), when compared with chest radiographs, reduces lung cancer specific mortality. The trial represented a merger of two NCI-sponsored activities, the NCI Lung Screening Study and the American College of Radiology Imaging Network (ACRIN). It enrolled more than 50,000 high-risk individuals (heavy current cigarette smokers or former smokers) from more than 30 sites across the United States. The ACRIN arm (ACRIN 6654) accrued 18,842 participants. These participants, aged 55 to 74 years, will be followed up http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository Originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654) Design, Intent, and Availability of Specimens for Validation of Lung Cancer Biomarkers

Aberle, Denise R.
Journal of Thoracic Oncology , Volume 5 (10) – Oct 1, 2010
Download PDF
5 pages

Loading next page...
 
/lp/wolters-kluwer-health/national-lung-cancer-screening-trial-american-college-of-radiology-AZdhpWS4hT

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1556-0864
DOI
10.1097/JTO.0b013e3181f1c634
pmid
20871260
Publisher site
See Article on Publisher Site

Abstract

EDITORIAL National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository Originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654) Design, Intent, and Availability of Specimens for Validation of Lung Cancer Biomarkers Edward F. Patz, Jr., MD,*† Neil E. Caporaso, PhD,‡ Steven M. Dubinett, MD,§ Pierre P. Massion, MD, Fred R. Hirsch, MD, PhD,¶ John D. Minna, MD,# Constantine Gatsonis, PhD,** Fenghai Duan, PhD,** Amanda Adams, MPH,** Charles Apgar, MBA,†† Rosa M. Medina, BS,†† and Denise R. Aberle, MD‡‡ he National Lung Cancer Screening Trial (NLST) is a cooperative, National Cancer TInstitute (NCI)-sponsored randomized trial that was initiated in 2002 with the primary goal to determine whether screening for lung cancer with computed tomography (CT), when compared with chest radiographs, reduces lung cancer specific mortality. The trial represented a merger of two NCI-sponsored activities, the NCI Lung Screening Study and the American College of Radiology Imaging Network (ACRIN). It enrolled more than 50,000 high-risk individuals (heavy current cigarette smokers or former smokers) from more than 30 sites across the United States. The ACRIN arm (ACRIN 6654) accrued 18,842 participants. These participants, aged 55 to 74 years, will be followed up

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Oct 1, 2010

References

  • Phases of biomarker development for early detection of cancer
    Pepe
  • CT screening for lung cancer: five-year prospective experience
    Swensen
  • The Danish randomized lung cancer CT screening trial—overall design and results of the prevalence round
    Pedersen
  • A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial
    Infante
  • Cancer statistics, 2009
    Jemal
  • Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner
    Sone
  • Panel of serum biomarkers for the diagnosis of lung cancer
    Patz
  • Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society
    MacMahon
  • The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
    Groome
  • Identification of small lung nodules at autopsy: implications for lung cancer screening and overdiagnosis bias
    Dammas
  • Lung cancer screening, overdiagnosis bias, and reevaluation of the Mayo Lung Project
    Patz
  • Extended lung cancer follow-up in the Mayo Lung Project and overdiagnosis
    Marcus
  • More lung cancer but better survival. Implications of secular trends in “necropsy surprise” rates
    Chan
  • Necropsy evidence of detection bias in the diagnosis of lung cancer
    McFarlane